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Abstract
Patients with haemorrhagic fever with renal syndrome (HFRS) may present without significant oliguria. We compared different initial
clinical symptoms and laboratory findings in patients who developed oliguric acute renal failure (ARF) with those in patients who did
not develop oliguric ARF. Overall, 128 patients with serologically confirmed HFRS were hospitalized at the University Hospital for Infec-
tious Disease, Zagreb, Croatia between January 1999 and December 2010. Clinical signs and laboratory findings were extracted from
medical charts, and were assessed for their relationship to the development of oliguric ARF. Puumala virus infection was diagnosed in
101 (79%) patients, and Dobrava-Belgrade virus infection in 27 (21%). Oliguria or anuria developed in 30% of patients. We identified
the following risk factors for the development of oliguria and anuria on multivariable analysis: conjunctival hyperaemia or bleeding (rela-
tive risk (RR) 1.84, 95% CI 1.09–3.10; p 0.023), diarrhoea (RR 1.45, 95% CI 1.07–1.97; p 0.017), serum sodium of £133 mM (RR 2.21,
95% CI 1.34–3.64; p 0.002), and dipstick protein value of >1.5 g/L (RR 1.59, 95% CI 1.09–2.33; p 0.016), as well as hiking in the forest
(RR 1.92, 95% CI 1.13–3.26; p 0.016). Our findings may help physicians in the earlier identification of patients with a more severe form
of HFRS caused by Puumala and Dobrava-Belgrade viruses. Particular attention should be given to findings such as conjunctival hypera-
emia or bleeding, diarrhoea, a low serum sodium level, and proteinuria.
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Introduction
The first four cases of haemorrhagic fever with renal syn-
drome (HFRS) were described in Croatia and south-eastern
Europe in 1954 [1]. In the following years, the disease
occurred mainly sporadically; however, a few outbreaks were
recorded as well [2–7], the largest of which was in 2002,
with >400 cases [8–10].
HFRS is an acute infectious disease caused by members of
the genus Hantavirus (family Bunyaviridae), and in Croatia is
mainly caused by Puumala virus and, to a lesser extent, by
Dobrava-Belgrade virus [4,9]. The most prominent symp-
toms of HFRS are fever, headache, and back pain. The
course of the disease usually has sequential phases: febrile,
hypotensive, oliguric, diuretic, and convalescent. However, a
considerable number of patients do not develop oliguria, and
overt haemorrhages are seldom found in cases of HFRS
caused by Puumala virus. It has been reported that Puumala
virus infection generally has a milder course, with a lower
case-fatality rate (<0.5%) [4,11,12], than Dobrava-Belgrade
virus infection (case-fatality rate of 5–15%) [13]. Haemodialy-
sis may be required in approximately 6–27% of hospitalized
patients with HFRS caused by Puumala virus infection [13–
15], and in approximately 20–40% of those with HFRS
caused by Dobrava-Belgrade virus [13].
We undertook a retrospective study of 128 hospitalized
patients with HFRS caused by Puumala and Dobrava-Belgrade
viruses to determine whether laboratory and clinical features
at admission to hospital can identify risk factors associated
with the development of oliguric acute renal failure (ARF) in
patients with HFRS.
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Materials and Methods
Study design and population
This was a retrospective study of consecutive HFRS patients
who were admitted to the University Hospital for Infectious
Diseases Zagreb, Croatia in the period from January 1999 to
December 2010. On the basis of clinical and epidemiological
findings, a total of 618 cases of HFRS were reported to the
Croatian National Institute of Public Health, Zagreb in the
period 1999–2010. Of these, 218 (35%) patients were trea-
ted at the University Hospital for Infectious Diseases Zagreb.
We reviewed laboratory and clinical records of all 218
patients with a clinical diagnosis of HFRS. Excluded from the
study were children younger than 18 years (n = 3, 1%) and
those with missing serological confirmation (n = 72, 33%).
We identified 143 (66%) such patients. Of 143 patients, 15
(10%) already had oliguria or anuria at the time of first evalu-
ation at our hospital. Hence, we included in the analysis 128
patients (59% of all patients) with a clinical diagnosis of HFRS
who did not have oliguria when first examined at the Univer-
sity Hospital for Infectious Diseases Zagreb.
Definitions
We assessed the following symptoms and signs of HFRS:
fever, headache, lumbar pain, vomiting, diarrhoea, conjuncti-
val hyperaemia or bleeding, and erythematous flush on the
face or neck. Oliguric ARF was evaluated for all patients at
and after admission to the hospital. All of our hospitalized
patients had 24-h urine output measurements performed.
Oliguria was classified as temporary loss of kidney function,
and refers to a 24-h urine output of £500 mL; anuria was
classified as a 24-h urine output of <50 mL.
Clinical and laboratory parameters
We obtained standard demographic data, clinical symptoms,
physical findings, laboratory findings and final diagnoses from
medical charts. The following blood or urine laboratory data
on the day of admission to the hospital were analysed: eryth-
rocyte sedimentation rate, C-reactive protein level, red
blood cell count, white blood cell count, platelet count,
plasma electrolyte levels, blood urea nitrogen level, serum
creatinine level, aspartate aminotransferase level, alanine ami-
notransferase level, serum protein electrophoresis, serum
albumin level, a2-globulin level, proteinuria, and the urine
sediment. Blood counts were determined and biochemical
tests were performed with routine analysers. Urine dipsticks
were routinely used. Proteinuria was defined when the dip-
stick measurement was equivalent to daily protein excretion
of >1.5 g/L. Of 128 patients, 112 (88%) had a C-reactive
protein measurement, and 99 (77%) had serum protein anal-
ysis, including serum albumin and a2-globulins. Chest X-rays
were performed in 113 (88%) patients.
The clinical diagnosis was confirmed serologically by
acute-phase serum in all 128 patients. In 105 (82%) patients,
the diagnosis of HFRS was based on IgM and IgG ELISA with
Hantaan, Puumala and Dobrava-Belgrade antigens (kindly
provided by T. G. Ksiazek and T. Avsˇicˇ Zˇupanc), as
described elsewhere [16]. The ELISA was used at the work-
place in the majority of patients to evaluate the presence of
specific IgM and IgG antibodies in serum samples, and sero-
typing was based on comparison of the absorbance values.
In 23 (18%) patients, the clinical diagnosis was confirmed
by point-of-care IgM (Reagena POC) for Dobrava, Hantaan
and Puumala viruses (Reagena Oy, Toivala, Finland), and
serotyping was based on band appearance in Reagena POC
Puumala or Reagena POC Dobrava–Hantaan tests or, in sev-
eral cases, on band intensity [17].
Statistical analysis
We present our data with frequencies for categorical
variables and medians with interquartile ranges (IQRs) for
quantitative variables. For comparison of oliguric or anuric
and non-oliguric groups, we used the Fisher exact test for
categorical variables and the Wilcoxon test for quantitative
variables.
We conducted log-binomial regression analysis to deter-
mine independent risk factors for developing oliguric ARF.
To explore continuous variables in the multivariable model,
we dichotomized them at the following values: red blood cell
count of ‡5.2 · 1012/L, platelet count of £50 · 109/L, blood
urea nitrogen level of ‡8.0 mM, serum creatinine level of
‡120 lM, serum sodium level of £133 mM, serum potassium
level of £3.5 mM, and serum chloride level of £97 mM. Vari-
ous combinations of variables were included in the multivari-
able model to evaluate the significance of each variable. We
also checked our model for multicollinearity and outliers.
Data analysis was performed with SAS version 9.1.3 (SAS
Institute, Cary, NC, USA). To calculate the relative risk, we
used the SAS procedure GENMOD to fit the log-binomal
method, and used the COPY method approximation to
obtain results [18]. A p-value of <0.05 was considered to be
statistically significant in all analyses.
Results
Baseline characteristics
The study included 128 patients. The median age of our
patients was 37 years (IQR 27–49 years), and 97 (76%) of
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them were male. The majority of patients 95 (74%) had been
exposed to the hantaviruses during the spring and summer
seasons from April to July.
At the time of admission, the median duration of illness
was 4 days (IQR 3–5 days). The most common symptom on
admission was fever; all patients had a temperature of
‡38.0C. During the course of the disease, the median value
of the highest recorded fever was 39.6C (IQR 39–40C),
and the median duration of fever was 8 days (IQR
6–11 days). Blurred vision was found more frequently in
females (13/31, 42%) than in males (21/97, 22%) (p 0.035). The
major clinical and laboratory characteristics of patients with
and without oliguria or anuria are compared in Tables 1 and 2.
Type of viral infection
Among the 128 patients, Puumala virus infection was con-
firmed in 101 (79%) and Dobrava-Belgrade virus infection in
27 (21%). Dobrava-Belgrade virus infection was not found
more frequently in patients with oliguria and/or anuria than
in patients with no oliguria or anuria. However, of the five
patients with anuria, four had Dobrava-Belgrade virus infec-
tion (rate: four of 27) and only one had Pumala virus infec-
tion (rate: one of 101) (p 0.007). Six patients needed
haemodialysis, of whom four were infected with the Dobra-
va-Belgrade virus and two with Puumala virus (p 0.018).
Patients with Dobrava-Belgrade virus infection had higher
levels of serum creatinine (median, 117 lM; IQR 91–
142 lM) than those with Puumala virus infection (median,
97 lM; IQR 86–117 lM) (p 0.076) The median level of
aspartate aminotransferase was also higher in patients with
Dobrava-Belgrade virus infection (57 U/L; IQR 46–80 U/L)
than in those with Puumala virus infection (39 U/L; IQR 32–
57 U/L; p 0.009).
Factors related to oliguria or anuria
Patients with oliguria or anuria were more likely than non-
oliguric patients to have headache, lumbar back pain, vomit-
ing, diarrhoea, blurred vision, flu-like symptoms, conjunctival
injection, and skin or nose bleeding, and to acquire the infec-
tion sporadically during hiking in the forest (Table 1).
Several laboratory abnormalities were associated with oli-
guric ARF in HFRS: the red blood cell and platelet counts,
and serum sodium, serum chloride and serum protein con-
centrations (Table 2). Proteinuria was found in 23 (26%) of
90 non-oliguric patients and in 16 (42%) of 38 patients who
subsequently developed oliguria (p 0.09).
In multivariable analysis, we examined the associations of
various risk factors with the presence of oliguria or anuria in
HFRS patients (Table 3). Clinical characteristics such as con-
junctival hyperaemia or bleeding, hiking to the forest and
diarrhoea on admission to hospital were consistently linked
to the presence or development of oliguria or anuria in
HFRS patients. Of the initial laboratory markers, a sodium
level in serum of £133 mM and proteinuria were consistently
associated with oliguria or anuria in HFRS patients.
Discussion
The majority of patients with HFRS caused by Dobrava-Bel-
grade and Puumala virus infection in Croatia are non-oliguric.
Several clinical signs were identified as risk factors for the
development of oliguria or anuria (Table 1), of which con-
junctival hyperaemia or bleeding was the most prominent. A
low sodium level was the most important laboratory finding
preceding oliguria, and exposure to Dobrava-Belgrade and
Puumala viruses in the forest was also a risk factor for more
severe illness.
There have been only a few small studies attempting to
identify risk factors for the development of oliguria and
anuria in HFRS. In a study from South Korea, factors such as
the leukocyte count, level of aspartate aminotransferase and
microscopic haematuria at admission were found to be useful
to predict the subsequent development of oliguric ARF in
HFRS [19]. However, this study included a relatively small
number of patients (n = 61), and HFRS was caused by Haan-
tan virus. Rasche et al. [14] compared eight patients with
ARF with seven with severe ARF, and found a lower platelet
count, a higher leukocyte count and a lower serum calcium
level in patients with more severe disease. As expected,
TABLE 1. Comparison of epidemiological and clinical char-
acteristics of patients with oliguric and non-oliguric acute
renal failure in haemorrhagic fever with renal syndrome at
time of admission
Characteristics
Oliguria or
anuria
present,
N = 38 (30)
Oliguria or
anuria not
present,
N = 90 (70) p-value
Gender, male 30 (79) 67 (74) 0.657
Age ‡38 years 16 (42) 45 (50) 0.444
Headache 37 (97) 73 (81) 0.013
Lumbar back pain 35 (92) 59 (66) 0.002
Vomiting 22 (58) 29 (32) 0.010
Diarrhoea 18 (47) 22 (24) 0.013
Blurred vision 17 (45) 17 (19) 0.004
Flu-like symptoms 20 (53) 30 (33) 0.049
Conjunctival hyperaemia
or bleeding
20 (53) 15 (17) <.001
Face and neck flushing 10 (26) 13 (14) 0.133
Skin or nose bleeding 8 (21) 3 (3) 0.003
Pulmonary involvementa 13 (36) 16 (21) 0.106
Dobrava-Belgrade vs.
Puumala virus
10 (26) 17 (19) 0.353
Hiking in the forest 14 (37) 15 (17) 0.020
Percentages are in parentheses.
aInformation was missing for 15 of the patients (12%).
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patients with severe ARF had more pronounced haematuria
and leukocyturia, and tubular cell casts. Avsˇicˇ et al. [13] com-
pared some clinical findings of Dobrava-Belgrade and Puumal-
a virus infections in a total of 31 patients from Slovenia in
1999, and found more deaths among patients with Dobrava-
Belgrade virus infection.
We found clinical signs of HFRS such as conjunctival hy-
peraemia, blurred vision, diarrhoea and back pain at a similar
frequency as in previous reports [4,8,13,14,19–23]. We
found a higher proportion of blurred vision in female
patients, but other risk factors associated with the severity
of the disease did not differ by sex. In population-based stud-
ies from China and Sweden, female patients experienced a
worse disease outcome [21,24]. Severe disease with oliguria
or anuria was generally associated with blurred vision,
conjunctival injection, and other clinical and laboratory
findings of severe HFRS 13,25.
Hyponatraemia and proteinuria were important risk
factors for the development of oliguria or anuria. They may
represent an early stage of ARF. Puumala and Dobrava-
Belgrade viruses cause increased systemic and local vascular
permeability [26]; both may contribute to acute kidney injury.
Elevated levels of creatinine are consistent with acute kid-
ney injury, and are frequently found in HFRS (74–99% of the
patients) [13,22,27]. Thrombocytopenia is a typical finding in
HFRS, and patients who develop oliguria or anuria have a
lower thrombocyte count than patients who do not develop
oliguria. However, thrombocytopenia is very frequently pres-
ent and correlated with other features of renal injury (hyp-
onatraemia and proteinuria), so it was not included as a
predictor in our multivariable analysis.
The whole Croatian inland area is considered to be ende-
mic for HFRS [4–6]. Both viruses are known to exist in
Croatia. Puumala virus generally causes milder forms of
HFRS than Dobrava-Belgrade virus [4,13]. Early studies found
that visual impairment, thrombocytopenia, a higher level of
serum creatinine, haemorrhage and signs of shock were
more common in patients with Dobrava-Belgrade virus infec-
tion [4,13]. We did not find a significant relationship
between Dobrava-Belgrade or Puumala virus infection and
blurred vision, thrombocytopenia, and levels of serum creati-
nine or the development of oliguria or anuria. However,
patients with anuria and those who required haemodialysis
were more frequently infected with Dobrava-Belgrade virus.
Hiking in the forest was associated with oliguria or anuria.
The type of viral infection (Dobrava-Belgrade vs. Puumala)
could not explain this finding. We can speculate that hiking in
the forest might be associated with entering an ecosystem
with a high density of small, wild rodents, probably resulting in
a higher exposure dose. It was reported that, among patients
with Dobrava-Belgrade virus infection, those with severe dis-
ease had, on average, higher viral RNA loads than those with
TABLE 2. Comparison of labora-
tory characteristics of patients
with oliguric and non-oliguric acute
renal failure in haemorrhagic fever
with renal syndrome at time of
admission
Oliguria or anuria
Yes = 38 (30%) No = 90 (70%)
Characteristic Median IQR Median IQR p-value
Erythrocyte sedimentation rate 40 24–55 35 26–50 0.886
C-reactive protein (mg/L)a 55 29–103 61 34–102 0.700
RBC count (· 1012/L) 5.1 4.7–5.4 4.9 4.5–5.1 0.029
WBC count (· 109/L) 8.2 6.5–10.0 7.9 6.4–10.1 0.616
Platelet count (· 109/lL) 58 36–80 73 54–94 0.011
Blood urea nitrogen (mM) 6.9 4.6–9.3 5.6 4.4–7.6 0.145
Creatinine in serum (lM) 108 91–143 97 86–119 0.060
Sodium in serum (mM) 133 131–136 136 135–138 <.001
Potassium in serum (mM) 3.9 3.7–4.1 3.9 3.7–4.0 0.401
Chloride in serum (mM) 97 95–99 98 96–101 0.027
Aspartate aminotransferase (U/L) 47 33–59 42 33–60 0.587
Alanine aminotransferase (U/L) 40 30–59 55 34–74 0.109
Protein, total in serum (g/L)b 65 62–70 69 65–74 0.040
Albumin in serum (g/L)b 37 32–41 38 35–41 0.210
WBCs in urine per high-power field 6 4–10 6 4–10 0.654
RBCs in urine per high-power field 6 3–11 6 4–14 0.506
IQR, interquartile range; RBC, red blood cell; WBC, white blood cell.
aInformation was missing for 16 of the patients (13.0%).
bInformation was missing for 29 of the patients (23.0%).
TABLE 3. Multivariable analysis of epidemiological, clinical
and laboratory findings of patients with haemorrhagic fever
with renal syndrome at time of admission to the hospital as
risk factors for the development of oliguria or anuria
Characteristics Relative risk 95% CI p-value
Conjunctival hyperaemia or bleeding 1.84 1.09–3.10 0.023
Diarrhoea 1.45 1.07–1.97 0.017
Serum sodium £133 mM 2.21 1.34–3.64 0.002
Proteinuria 1.59 1.09–2.33 0.016
Hiking in the forest 1.92 1.13–3.26 0.016
The relative risk reports the risk of developing oliguria or anuria for individual
characteristics (yes vs. no).
The parameters were also adjusted for the duration of illness before admission
to hospital.
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a milder disease course [28]. However, our finding needs to
be interpreted with caution until additional virological and epi-
demiological evidence is gathered to support the notion that
forest hiking is associated with more severe disease.
This study has several limitations. This was an observa-
tional cross-sectional study, so cause–effect relationships can-
not be determined. Our patients were enrolled over a period
of 11 years, including one epidemic year. Given the yearly
variability, it is possible that, in the epidemic year during
which the half of the study population was selected, the
course of disease was unusually mild. This study included a
substantial number of Puumala virus infections and a relatively
small number of Dobrava-Belgrade virus infections, so the dif-
ference in clinical findings could not be fully assessed. Also,
some predictors (e.g. headache, lumbar back pain, and skin or
nose bleeding) could not be evaluated in our multivariable
model, because too many or too few patients had these
features. Also, some variables were omitted because of con-
cerns about multicollinearity (e.g. blurred vision and conjunc-
tival hyperaemia). Nevertheless, we studied a relatively large
cohort of patients with HFRS, and believe that we identified a
number of important risk factors for oliguria or anuria.
We recommend careful evaluation of factors such as con-
junctival injection and diarrhoea, as well as laboratory find-
ings, e.g. a low sodium level of £133 mM, and estimated
proteinuria of >1.5 g/L, early in the course of HFRS caused
by Dobrava-Belgrade and Puumala viruses. Our findings may
help physicians in the earlier identification of patients with a
more severe form of HFRS.
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